91121-60-7Relevant academic research and scientific papers
Compounds advantageous in the treatment of central nervous system diseases and disorders
-
, (2015/12/25)
A series of novel compounds showing anticonvulsant activity is described. Such pharmaceutically active compounds may also show utility in the treatment of other central nervous system (“CNS”) diseases and disorders, such as anxiety, depression, insomnia,
Polyprenyl compounds
-
, (2008/06/13)
A polyprenyl compound terminated with a group of STR1 is novel and useful as an antihypercholesterolemic agent and an antiarteriosclerotic agent, in which X is a group of the formula STR2 (wherein K and L are independently a hydrogen atom or form a single valence bond between the carbon atoms to which they are attached), a group represented by the formula --CH2 -- or a group represented by the formula --(CH2)2 --, m is an integer of 0 or 1, and R stands for a hydroxy group, a group represented by the formula STR3 wherein R1 and R2 may be the same or different and each stands for a hydrogen atom or a lower alkyl group and p stands for an integer of 1 or 2, a group represented by the formula --NH--(CH2)q --OH (wherein q denotes an integer of 1 or 2) or a group represented by the formula
